NCT00095472View on ClinicalTrials.gov

Therapeutic Application of Intravascular Nitrite for Sickle Cell Disease

PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

November 1, 2004

Primary Completion Date

August 24, 2007

Study Completion Date

August 24, 2007

Conditions
Sickle Cell Anemia
Interventions
DRUG

L-NMMA

DRUG

Sodium Nitrite

Trial Locations (1)

20892

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

All Listed Sponsors
lead

National Heart, Lung, and Blood Institute (NHLBI)

NIH

NCT00095472 - Therapeutic Application of Intravascular Nitrite for Sickle Cell Disease | Biotech Hunter | Biotech Hunter